
mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify both known and novel transcript isoforms, gene fusions, and other features as well as allele-specific expression. mRNA-Seq delivers a complete view of the coding transcriptome that is not restricted by the filter of prior knowledge.
Market Analysis and Insights: Global mRNA Sequencing Market
The global mRNA Sequencing market is projected to grow from US$ 3315 million in 2024 to US$ 8813.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 17.7% during the forecast period.
A significant driver in the mRNA Sequencing market is the rapid advancements in genomics research and the growing interest in studying gene expression at the mRNA level. mRNA sequencing, also known as RNA-Seq, provides a powerful tool for understanding the transcriptome and identifying differentially expressed genes across various biological conditions. However, a notable challenge in this market is the need for data analysis and standardization. Ensuring that researchers can efficiently analyze and interpret the vast amount of mRNA sequencing data generated while addressing potential variations in protocols and data processing poses a significant challenge. Bioinformatics solutions, data analysis pipelines, and data-sharing standards must be continuously developed to facilitate data interpretation and integration, promoting the widespread adoption of mRNA sequencing in genomics research and clinical applications.
Report Covers:
This report presents an overview of global market for mRNA Sequencing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of mRNA Sequencing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for mRNA Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Sequencing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global mRNA Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for mRNA Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of mRNA Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Sequencing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Sequencing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global mRNA Sequencing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Sequencing Market Perspective (2019-2030)
2.2 Global mRNA Sequencing Growth Trends by Region
2.2.1 mRNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Sequencing Historic Market Size by Region (2019-2024)
2.2.3 mRNA Sequencing Forecasted Market Size by Region (2025-2030)
2.3 mRNA Sequencing Market Dynamics
2.3.1 mRNA Sequencing Industry Trends
2.3.2 mRNA Sequencing Market Drivers
2.3.3 mRNA Sequencing Market Challenges
2.3.4 mRNA Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue mRNA Sequencing by Players
3.1.1 Global mRNA Sequencing Revenue by Players (2019-2024)
3.1.2 Global mRNA Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of mRNA Sequencing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global mRNA Sequencing Market Concentration Ratio
3.4.1 Global mRNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Sequencing Revenue in 2023
3.5 Global Key Players of mRNA Sequencing Head office and Area Served
3.6 Global Key Players of mRNA Sequencing, Product and Application
3.7 Global Key Players of mRNA Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Sequencing Breakdown Data by Type
4.1 Global mRNA Sequencing Historic Market Size by Type (2019-2024)
4.2 Global mRNA Sequencing Forecasted Market Size by Type (2025-2030)
5 mRNA Sequencing Breakdown Data by Application
5.1 Global mRNA Sequencing Historic Market Size by Application (2019-2024)
5.2 Global mRNA Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Sequencing Market Size (2019-2030)
6.2 North America mRNA Sequencing Market Size by Type
6.2.1 North America mRNA Sequencing Market Size by Type (2019-2024)
6.2.2 North America mRNA Sequencing Market Size by Type (2025-2030)
6.2.3 North America mRNA Sequencing Market Share by Type (2019-2030)
6.3 North America mRNA Sequencing Market Size by Application
6.3.1 North America mRNA Sequencing Market Size by Application (2019-2024)
6.3.2 North America mRNA Sequencing Market Size by Application (2025-2030)
6.3.3 North America mRNA Sequencing Market Share by Application (2019-2030)
6.4 North America mRNA Sequencing Market Size by Country
6.4.1 North America mRNA Sequencing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America mRNA Sequencing Market Size by Country (2019-2024)
6.4.3 North America mRNA Sequencing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe mRNA Sequencing Market Size (2019-2030)
7.2 Europe mRNA Sequencing Market Size by Type
7.2.1 Europe mRNA Sequencing Market Size by Type (2019-2024)
7.2.2 Europe mRNA Sequencing Market Size by Type (2025-2030)
7.2.3 Europe mRNA Sequencing Market Share by Type (2019-2030)
7.3 Europe mRNA Sequencing Market Size by Application
7.3.1 Europe mRNA Sequencing Market Size by Application (2019-2024)
7.3.2 Europe mRNA Sequencing Market Size by Application (2025-2030)
7.3.3 Europe mRNA Sequencing Market Share by Application (2019-2030)
7.4 Europe mRNA Sequencing Market Size by Country
7.4.1 Europe mRNA Sequencing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe mRNA Sequencing Market Size by Country (2019-2024)
7.4.3 Europe mRNA Sequencing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China mRNA Sequencing Market Size (2019-2030)
8.2 China mRNA Sequencing Market Size by Type
8.2.1 China mRNA Sequencing Market Size by Type (2019-2024)
8.2.2 China mRNA Sequencing Market Size by Type (2025-2030)
8.2.3 China mRNA Sequencing Market Share by Type (2019-2030)
8.3 China mRNA Sequencing Market Size by Application
8.3.1 China mRNA Sequencing Market Size by Application (2019-2024)
8.3.2 China mRNA Sequencing Market Size by Application (2025-2030)
8.3.3 China mRNA Sequencing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia mRNA Sequencing Market Size (2019-2030)
9.2 Asia mRNA Sequencing Market Size by Type
9.2.1 Asia mRNA Sequencing Market Size by Type (2019-2024)
9.2.2 Asia mRNA Sequencing Market Size by Type (2025-2030)
9.2.3 Asia mRNA Sequencing Market Share by Type (2019-2030)
9.3 Asia mRNA Sequencing Market Size by Application
9.3.1 Asia mRNA Sequencing Market Size by Application (2019-2024)
9.3.2 Asia mRNA Sequencing Market Size by Application (2025-2030)
9.3.3 Asia mRNA Sequencing Market Share by Application (2019-2030)
9.4 Asia mRNA Sequencing Market Size by Region
9.4.1 Asia mRNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia mRNA Sequencing Market Size by Region (2019-2024)
9.4.3 Asia mRNA Sequencing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America mRNA Sequencing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Type
10.2.1 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America mRNA Sequencing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Application
10.3.1 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America mRNA Sequencing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Country
10.4.1 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America mRNA Sequencing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific mRNA Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in mRNA Sequencing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina mRNA Sequencing Introduction
11.2.4 Illumina Revenue in mRNA Sequencing Business (2019-2024)
11.2.5 Illumina Recent Developments
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) mRNA Sequencing Introduction
11.3.4 QIAGEN (Exiqon) Revenue in mRNA Sequencing Business (2019-2024)
11.3.5 QIAGEN (Exiqon) Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies mRNA Sequencing Introduction
11.4.4 Agilent Technologies Revenue in mRNA Sequencing Business (2019-2024)
11.4.5 Agilent Technologies Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche mRNA Sequencing Introduction
11.5.4 Roche Revenue in mRNA Sequencing Business (2019-2024)
11.5.5 Roche Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare mRNA Sequencing Introduction
11.6.4 GE Healthcare Revenue in mRNA Sequencing Business (2019-2024)
11.6.5 GE Healthcare Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories mRNA Sequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in mRNA Sequencing Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 Fluidigm
11.8.1 Fluidigm Company Details
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm mRNA Sequencing Introduction
11.8.4 Fluidigm Revenue in mRNA Sequencing Business (2019-2024)
11.8.5 Fluidigm Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Ìý
Ìý
*If Applicable.
